Book a Demo
Platform Overview
Features
Cardiac Amyloidosis Heart Failure Aortic Stenosis Pulmonary Hypertension Strain Stress Echocardiography
Operations
Operational Impact Deployment & Security Integrations Core Lab Solutions EHR Mining Partnerships
Tools
ROI Calculator Reimbursements Peer Comparison Regulatory Status
Library & news
Clinical Evidence Case Studies News
Our Story Careers Media Kit

Reimbursement in Additional Markets

Coding and reimbursement summary for nine additional markets where Us2.ai is cleared or registered: Singapore, New Zealand, UAE, Hong Kong, Malaysia, Indonesia, Vietnam, Israel, and Jordan.

See all markets

Why These Markets are Grouped

Each market on this page is one where Us2.ai holds regulatory clearance or registration, and where the local reimbursement framework is well-documented but does not yet warrant its own dedicated deep-dive page. Bundled coverage makes it easy to compare schemes at a glance and decide which warrant a more detailed customer-specific brief.

Reimbursement Summary by Market

Scheme name, headline coding architecture, and indicative pricing for each market. Indicative figures are for planning; verify against the live local schedule.

Singapore

MediShield Life / MOH FBAC

MediShield Life provides catastrophic-illness coverage; out-of-pocket is the dominant payment model for routine outpatient echo, with MOH FBAC advisory benchmarks. Restructured hospitals use ICD-10-PCS for procedural coding.

Coding
ICD-10-PCS
Indicative TTE
SGD 200–600 (subsidised)
Indicative stress echo
SGD 500–1,500
Authority
MOH FBAC advisory
Regulator
HSA (Class B)

New Zealand

Te Whatu Ora (Health New Zealand)

Hospital and community echo is funded through the Te Whatu Ora budget envelope rather than a per-procedure schedule. There is no MBS-equivalent fee-for-service for publicly funded studies; private cardiology operates separately.

Funding
Te Whatu Ora budget envelope
Coding
NZ-specific procedure classification
Private
Cardiologist-set fee schedule
Regulator
Medsafe

United Arab Emirates

DHA (Dubai) / DoH (Abu Dhabi) IR-DRG + CPT

Both DHA and DoH use US CPT codes for outpatient claims (via eClaimLink in Dubai) and the International Refined DRG (IR-DRG) system for inpatient billing. CPT 93306 anchors TTE; CPT 93350 / 93351 anchor stress echo.

Authority
DHA / DoH (HAAD)
Outpatient code
CPT 93306 (TTE)
Stress echo
CPT 93350 / 93351
Inpatient
IR-DRG bundled
Indicative TTE
AED 400–1,500
Regulator
MOHAP

Hong Kong

Hospital Authority + VHIS

Public sector under Hospital Authority operates on flat patient fees with internal budget. Following the 2026 fee reform (effective 1 January 2026), specialist outpatient is HKD 250 (up from 135), general outpatient is HKD 150 (up from 50), and inpatient daily charge is HKD 200–300 (up from 120), with a new annual fee cap of HKD 10,000 per patient. Private sector and Voluntary Health Insurance Scheme (VHIS) operate on insurer schedules using ICD-10-PCS.

Public
HA bundled care
HA specialist OP (2026)
HKD 250 (was 135)
HA inpatient daily (2026)
HKD 200–300 (was 120)
Annual cap
HKD 10,000 per patient
Private
VHIS insurer schedules
Indicative private
HKD 1,500–6,000
Coding
ICD-10-AM (HA) / ICD-10-PCS (private)
Regulator
MDACS

Malaysia

MOH public + PHFSA private

Public MOH services are heavily subsidised (RM 1–5 registration fee, no item code schedule). Private hospitals follow the PHFSA (Private Healthcare Facilities and Services Act) schedule. MySalam offers lump-sum critical-illness payouts but not per-procedure reimbursement.

Public
MOH subsidised (RM 1–5 co-pay)
Private
PHFSA-aligned schedule
Indicative private TTE
MYR 300–1,000
MySalam
Lump-sum critical-illness payouts
Regulator
MDA

Indonesia

BPJS Kesehatan INA-CBG

BPJS Kesehatan uses the INA-CBG case-mix system (Permenkes 3/2023) with over 1,075 inpatient and 288 outpatient case groups. Echo is bundled within the relevant cardiac CBG; hospital class (A/B/C/D) affects the rate.

Scheme
BPJS Kesehatan
Inpatient
INA-CBG bundled (1,075+ groups)
Outpatient
288 outpatient CBG groups
Indicative outpatient
IDR 250,000–500,000
Hospital class
A / B / C / D affects rate
Regulator
Kemenkes

Vietnam

BHYT / MOH

Bảo hiểm Y tế (BHYT) covers 80–100% depending on category and referral chain. Hospital tier (hạng I / II / III) affects the rate. MOH publishes the imaging schedule per Decisions 2775/QD-BYT and 2776/QD-BYT (2025).

Scheme
BHYT / MOH
Indicative 2D TTE
VND 130,000–180,000
Indicative Doppler
VND 150,000–220,000
Stress echo
VND 400,000–700,000
Tier I only
Stress echo restricted to hạng I
Regulator
MOH Vietnam

Israel

Sal Briut via Kupot Holim

The National Health Insurance Basket (Sal Sherutei Briut, governed by the National Health Insurance Law) covers echo studies for all four HMOs (Clalit, Maccabi, Meuhedet, Leumit). Each HMO operates its own network of cardiology services within the basket scope.

Scheme
Sal Sherutei Briut (national basket)
HMOs
Clalit, Maccabi, Meuhedet, Leumit
Indicative TTE
ILS 350–900
Coverage
Universal under NHI Law
Regulator
AMAR (Ministry of Health)

Jordan

RMS / MoH / private (e.g. Globemed)

The Royal Medical Services covers military personnel and select civil servants. The Ministry of Health covers the general population at public hospitals. Private insurers (Globemed, NewMed, AlNisr Alarabi, etc.) maintain their own schedules.

Public RMS
Military / civil-servant pool
Public MoH
General population
Private
Globemed and other insurer schedules
Indicative TTE
JOD 50–150
Regulator
JFDA

All indicative ranges reflect the current local schedule at time of writing. Hospital tier, insurer contracts, and bundled DRG / CBG case payments materially affect actual paid amounts. Verify against the live local schedule before relying on figures for financial planning.

Model the impact across your portfolio

Plug in your annual echo volume per market and the relevant local fee or bundle to estimate net new capacity from AI-assisted reporting.

Procurement & Regulatory Context

Across these nine markets, three procurement themes recur: medical-device registration, local data-protection law, and APAC-region or sovereign cloud hosting.

Medical Device Registration

Us2.ai holds registration with HSA (SG), Medsafe (NZ), MOHAP (UAE), MDACS (HK), MDA (MY), Kemenkes (ID), MOH Vietnam, AMAR (IL), and JFDA (JO).

Local Data Protection

Singapore PDPA, NZ Privacy Act, UAE PDPL, Hong Kong PDPO, Malaysia PDPA, Indonesia PDP Law, Vietnam PDP Decree, Israel Privacy Protection Law, and Jordan Personal Data Protection Law each carry market-specific requirements.

Sovereign & Regional Cloud

APAC-region cloud hosting (Singapore, Sydney, Tokyo, Mumbai), Middle East-region cloud (UAE), and on-premise deployment options are available to meet local data residency policy.

Frequently Asked Questions

Common questions about echocardiography reimbursement across these additional markets.

Why are these markets grouped on one page?
Each market on this page has a well-documented reimbursement framework, but the spreadsheet-level depth (number of distinct procedure codes with published tariffs) is modest. Bundling them on a single page makes comparison easier without inflating each into a separate page. Per-market deep dives can be split out later as data matures.
Which markets have the strongest reimbursement signal for AI echo?
Within this group, UAE (DHA + DoH using CPT and IR-DRG) and Israel (national Sal Briut with established HMO networks) carry the clearest published per-procedure pricing. Singapore and Hong Kong have material self-pay and private insurance markets; Indonesia and Vietnam are heavily case-mix bundled.
How does universal coverage affect AI echo deployment?
Several of these markets operate universal coverage with fixed per-case or per-capita payment (Indonesia INA-CBG, NZ Te Whatu Ora budget, Israel Sal Briut). In those settings AI value is throughput and report quality rather than incremental per-study revenue. Mixed public-private markets (UAE, HK, MY, SG) carry both volume and pricing value cases.
Is Us2.ai cleared in all nine markets?
Yes. Us2.ai holds regulatory clearance or registration in all nine markets summarised here. See the Regulatory Status page for the full clearance list across 28+ markets.
Where can I get a per-market deep-dive?
Contact us for any of these markets in detail. Country-specific customer briefs are available with current scheme context, regulatory documentation, and clinical evidence tailored to your buying centre.
What about Saudi Arabia, Egypt, and other Middle East markets?
Saudi Arabia (NPHIES SBS) and Egypt (UHIA) are covered in the global reimbursement dataset but Us2.ai\'s current clearance set focuses on the markets shown here. For confirmation of clearance status in any specific market, contact us with your country and intended use.

Important Information

Information is provided for general informational purposes only and is not a guarantee of coverage or reimbursement. Local schedules, hospital tier classifications, case-mix group rates, and insurer contracts are subject to change. Providers should verify against the relevant local authority before relying on figures for financial planning. This information does not constitute legal, financial, or billing advice.

Need detail on a specific market?

Country-specific customer briefs are available with current scheme context, regulatory documentation, and clinical evidence tailored to your team.

Contact Us